Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Colling

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|October 3, 2019
CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United KingdomPhilip S Macklin, Nischalan Pillay, Jessica L Lee, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
BJUI Compass|September 26, 2024
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohortThineskrishna Anbarasan, Mutie Raslan, Kanchan Ghosh, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
JAMA Oncology|October 16, 2025
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical TrialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
European Urology Oncology|June 25, 2026
Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or RadiotherapyNikita Sushentsev, Richard Colling, Renuka Teague, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2023
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older PatientsMitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2020
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older PatientsMitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Cell|May 10, 2024
Analysis of 3D pathology samples using weakly supervised AIAndrew H Song, Mane Williams, Drew F K Williamson, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|October 3, 2019
CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United KingdomPhilip S Macklin, Nischalan Pillay, Jessica L Lee, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
BJUI Compass|September 26, 2024
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohortThineskrishna Anbarasan, Mutie Raslan, Kanchan Ghosh, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
JAMA Oncology|October 16, 2025
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical TrialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
European Urology Oncology|June 25, 2026
Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or RadiotherapyNikita Sushentsev, Richard Colling, Renuka Teague, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2023
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older PatientsMitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2020
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older PatientsMitchell E Fane, Brett L Ecker, Amanpreet Kaur, et al.
Cell|May 10, 2024
Analysis of 3D pathology samples using weakly supervised AIAndrew H Song, Mane Williams, Drew F K Williamson, et al.
Pageof 6